Published in Biochim Biophys Acta on October 05, 1979
How is the level of free arachidonic acid controlled in mammalian cells? Biochem J (1982) 3.96
Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J (1993) 3.41
Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids. J Clin Invest (1980) 1.67
The phosphoinositides exist in multiple metabolic pools in rabbit platelets. Biochem J (1986) 0.92
Subcellular localization of inositol lipids in blood platelets as deduced from the use of labelled precursors. Biochem J (1987) 0.86
Modulation of the phase heterogeneity of aminoglycerophospholipid mixtures by sphingomyelin and monovalent cations: maintenance of the lamellar arrangement in the biological membranes. Eur Biophys J (2004) 0.79
Selective internalization of arachidonic acid by endothelial cells. Biochem J (1987) 0.76
Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase. Biochimie (1978) 1.56
Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom (2005) 1.32
Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta (1977) 1.31
The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci (2005) 1.26
Sphingomyelinases and Niemann-Pick disease. J Clin Chem Clin Biochem (1986) 1.16
Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. Nature (1981) 1.15
Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim Biophys Acta (1984) 1.11
Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection. Eur J Pediatr (1988) 1.09
Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem (1994) 1.09
Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem Biophys Res Commun (1982) 1.05
Characterization and properties of a phosphatidylinositol phosphodiesterase (phospholipase C) from platelet cytosol. FEBS Lett (1979) 1.04
Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Biochem Biophys Res Commun (1998) 1.03
Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci (2006) 0.99
An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS (2001) 0.99
Biochemical characterization of plasma membranes and intracellular membranes isolated from human platelets using Percoll gradients. Biochim Biophys Acta (1986) 0.99
Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. Biochim Biophys Acta (1990) 0.98
Isolation and characterization of plasma membranes from krebs II ascite cells using Percoll gradient. Biochim Biophys Acta (1982) 0.97
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. FEBS Lett (1983) 0.97
Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis (2005) 0.96
[CMP-aminoethylphosphonate: intermediary in the phosphonolipids of the rat liver]. Biochimie (1973) 0.95
Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy. J Clin Endocrinol Metab (2001) 0.93
Genetic structure of Trypanosoma cruzi populations from Argentina estimated from enzyme polymorphism. Parasitology (1993) 0.92
Identification and quantification of diacylglycerols in HDL and accessibility to lipase. J Lipid Res (1996) 0.92
Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res (1994) 0.92
New insight on the molecular mechanisms of high-density lipoprotein cellular interactions. Cell Mol Life Sci (2004) 0.91
Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell. I. Chemical modifications of ultraviolet-treated low-density lipoproteins. Biochim Biophys Acta (1990) 0.90
Vascular smooth muscle cell spreading onto fibrinogen is regulated by calpains and phospholipase C. Biochem Biophys Res Commun (2001) 0.89
Lipid products of phosphoinositide 3-kinase and phosphatidylinositol 4',5'-bisphosphate are both required for ADP-dependent platelet spreading. J Biol Chem (1998) 0.89
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res (1987) 0.89
Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy. Biochim Biophys Acta (1987) 0.89
Activation of phospholipase C in thrombin-stimulated platelets does not depend on cytoplasmic free calcium concentration. FEBS Lett (1984) 0.88
Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health (2002) 0.88
Purification of two lipases with high phospholipase A1 activity from guinea-pig pancreas. Biochim Biophys Acta (1981) 0.88
Structural and functional comparison of HDL from homologous human plasma and follicular fluid. A model for extravascular fluid. Arterioscler Thromb Vasc Biol (1997) 0.88
High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2). Biochemistry (1996) 0.87
Phospholipase C from human sperm specific for phosphoinositides. Biochim Biophys Acta (1987) 0.87
Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C. Biochim Biophys Acta (1986) 0.87
Pathways of arachidonic acid liberation in thrombin and calcium ionophore A23187-stimulated human endothelial cells: respective roles of phospholipids and triacylglycerol and evidence for diacylglycerol generation from phosphatidylcholine. Biochim Biophys Acta (1987) 0.86
Hydrolysis of fluorescent pyrenetriacylglycerols by lipases from human stomach and gastric juice. Biochim Biophys Acta (1988) 0.86
Calcium ionophore A 23187 induces arachidonic acid release from phosphatidylcholine in cultured human endothelial cells. Biochem Biophys Res Commun (1981) 0.86
Evidence for the activation of phospholipases during acrosome reaction of human sperm elicited by calcium ionophore A23187. Biochim Biophys Acta (1987) 0.86
Subcellular localization of inositol lipids in blood platelets as deduced from the use of labelled precursors. Biochem J (1987) 0.86
Biochemical and physical properties of remnant-HDL2 and of pre beta 1-HDL produced by hepatic lipase. Biochemistry (1999) 0.86
Potential anticoagulant activity of lipocortins and other calcium/phospholipid binding proteins. Biochem Biophys Res Commun (1988) 0.86
Characterization of plasma membranes from A431 cells, isolated by self-generating Percoll gradient: a rapid isolation procedure to obtain plasma membranes with functional epidermal growth factor receptors. Biochim Biophys Acta (1988) 0.85
Studies of endogenous polyphosphoinositide hydrolysis in human platelet membranes. Evidence that polyphosphoinositides remain inaccessible to phosphodiesterase in the native membrane. Biochim Biophys Acta (1986) 0.85
Pre-beta HDL: structure and metabolism. Biochim Biophys Acta (1996) 0.85
Metabolism of neutral lipids in cultured fibroblasts from multisystemic (or type 3) lipid storage myopathy. Eur J Biochem (1987) 0.85
Characterization of Trypanosoma cruzi from Argentina by electrophoretic zymograms. Acta Trop (1991) 0.85
Studies on enzymes related to diacylglycerol production in activated platelets. II. Subcellular distribution, enzymatic properties and positional specificity of diacylglycerol- and monoacylglycerol-lipases. Biochim Biophys Acta (1984) 0.84
Studies on enzymes related to diacylglycerol production in activated platelets. I. Phosphatidylinositol-specific phospholipase C: further characterization using a simple method for determination of activity. Biochim Biophys Acta (1984) 0.84
Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol (1987) 0.84
Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study. Atherosclerosis (2011) 0.84
Isolation of two 67 kDa calcium-binding proteins from pig lung differing in affinity for phospholipids and in anti-phospholipase A2 activity. FEBS Lett (1987) 0.84
Lipoprotein and phospholipid distribution in human follicular fluids. Fertil Steril (1985) 0.84
Evidence that biosynthesis of platelet-activating factor (paf-acether) by human neutrophils occurs in an intracellular membrane. FEBS Lett (1985) 0.84
Studies on ether phospholipids. I. A new method of determination using phospholipase A1 from guinea pig pancreas: application to Krebs II ascites cells. Biochim Biophys Acta (1984) 0.84
Metabolism of pyrenedecanoic acid in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and from a patient with multisystemic lipid storage myopathy. Biochim Biophys Acta (1989) 0.83
Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core. Biochemistry (1996) 0.83
High density lipoprotein and low density lipoprotein utilization by human granulosa cells for progesterone synthesis in serum-free culture: respective contributions of free and esterified cholesterol. J Clin Endocrinol Metab (1987) 0.83
Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2). Biochemistry (1998) 0.83
[Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)]. Eur J Biochem (1981) 0.83
Characterization of a G protein-activated phosphoinositide 3-kinase in vascular smooth muscle cell nuclei. J Biol Chem (2001) 0.83
Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls. J Clin Densitom (2007) 0.83
Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. Biochem Biophys Res Commun (1985) 0.83
Use of a fluorescent radiolabeled triacylglycerol as a substrate for lipoprotein lipase and hepatic triglyceride lipase. Lipids (1988) 0.83
Are polyphosphoinositides involved in platelet activation? Biochem Biophys Res Commun (1983) 0.82
Lymphoid cell lines as a model system for the study of Wolman's disease: enzymatic, metabolic and ultrastructural investigations. J Inherit Metab Dis (1986) 0.82
Independence of triacylglycerol-containing compartments in cultured fibroblasts from Wolman disease and multisystemic lipid storage myopathy. FEBS Lett (1989) 0.82
Sex-hormone-binding globulin and protein-energy malnutrition indexes as indicators of nutritional status in women with anorexia nervosa. Am J Clin Nutr (1993) 0.82
A rapid isolation procedure of plasma membranes from human neutrophils using self-generating Percoll gradients. Importance of pH in avoiding contamination by intracellular membranes. Biochim Biophys Acta (1985) 0.82
Effects of two methylxanthines, pentoxifylline and propentofylline, on arachidonic acid metabolism in platelets stimulated by thrombin. Biochem Pharmacol (1988) 0.82
Evidence for a highly asymmetric arrangement of ether- and diacyl-phospholipid subclasses in the plasma membrane of Krebs II ascites cells. Biochim Biophys Acta (1984) 0.82
Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. Biochim Biophys Acta (1997) 0.81
Separation and properties of molecular forms of alpha-galactosidase and alpha-N-acetylgalactosaminidase from blood lymphocytes and lymphoid cell lines transformed by Epstein-Barr virus. Biochim Biophys Acta (1981) 0.81
Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia. Biochem Biophys Res Commun (1984) 0.81
An in vitro study of hemicholinium-3 on phospholipid metabolism of Krebs II ascites cells. Biochem Pharmacol (1983) 0.81
Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolman's disease. Eur J Biochem (1987) 0.81
Organization and role of platelet membrane phospholipids as studied with purified phospholipases. Agents Actions (1979) 0.81
Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease. Atherosclerosis (1999) 0.81
Chemical analysis of the bronchoalveolar washing fluid in the diagnosis of liquid paraffin pneumonia. J Clin Chem Clin Biochem (1987) 0.81
Effect of PCR 4099 on ADP-induced calcium movements and phosphatidic acid production in rat platelets. Biochem Pharmacol (1988) 0.80
Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort. Diabetes Metab (2006) 0.80
[Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease]. Biomedicine (1980) 0.80
Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore properties. FEBS Lett (1984) 0.80
Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease. FEBS Lett (1983) 0.80
Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites. Biochemistry (1994) 0.80
Phospholipid exchange proteins from platelet cytosol possibly involved in phospholipid effect. Biochem Biophys Res Commun (1981) 0.80
Enzyme studies on Epstein-Barr virus-transformed lymphoid cell lines from Wolman's disease. Lipases, cholesterol esterase and 4-methylumbelliferyl acyl ester hydrolases. Biochim Biophys Acta (1984) 0.79
Effects of an antimitotic agent (cyclophosphamide) on plasma lipoproteins. Biochem Pharmacol (1984) 0.79
[Phospholipase C-induced release reaction in platelets (author's transl)]. Eur J Biochem (1974) 0.79
Organization and role of platelet membrane phospholipids as studied with phospholipases A2 from various venoms and phospholipases C from bacterial origin. Toxicon (1982) 0.79
[Prevalence of dyslipidaemias in a representative sample of the French population]. Arch Mal Coeur Vaiss (2005) 0.79
Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. Atherosclerosis (1989) 0.79
Effect of a stimulant of guanylate cyclase, sin 1, on calcium movements and phospholipase C activation in thrombin-stimulated human platelets. Biochem Pharmacol (1988) 0.78